retatrutide clinical trial brazil ESC 2024: Retatrutide improves lipid and cardiovascular risk profile in Phase II retatrutide clinical trials brazil Reta

Side effects are always important to know, and [patients should] understand that theres no miracle drug, Bakshi says

If retatrutide produces better weight loss but costs significantly more, NICE may restrict it to specific patient groups while Mounjaro remains the first-line option

If youre ready to explore retatrutide but want to make sure its done safely, were ready to help

2 What the ATTAIN-1 trial showed ATTAIN-1 was a Phase 3 trial (a large human trial with thousands of participants) enrolling 3,127 adults with obesity but without type 2 diabetes

Same manufacturer

Prime will release findings of its research on cost-of-care implications for GLP-1 therapy for obesity at three years later this year